Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 24 Issue: 37, November 2017



Editorial: Epigenetics: A Novel Frontier For Drug Discovery free to download

Volume:24   Issue: 37
Pp: 4103-4103
Shabir Ahmad Ganai
DOI: 10.2174/092986732437171201120621
Published on: 01 December, 2017



Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders

Volume:24   Issue: 37
Pp: 4104-4120
Shabir A. Ganai*
DOI: 10.2174/0929867324666170209104030
Published on: 08 February, 2017




Epigenetic Modulation Using Small Molecules - Targeting Histone Acetyltransferases in Disease

Volume:24   Issue: 37
Pp: 4121-4150
Andre Richters and Angela N. Koehler*
DOI: 10.2174/0929867324666170223153115
Published on: 23 February, 2017




HDACs and HDAC Inhibitors in Urothelial Carcinoma – Perspectives for an Antineoplastic Treatment

Volume:24   Issue: 37
Pp: 4151-4165
Maria Pinkerneil, Michele J. Hoffmann, Wolfgang A. Schulz and Gunter Niegisch*
DOI: 10.2174/0929867324666170207142740
Published on: 07 February, 2017




Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer

Volume:24   Issue: 37
Pp: 4166-4179
Kai Cheng, Siyu Li and Chenzhong Liao*
DOI: 10.2174/0929867324666170209105315
Published on: 08 February, 2017




A Review of Recent Advancements in Anti-tubercular Molecular Hybrids

Volume:24   Issue: 37
Pp: 4180-4212
Parvesh Singh*, Bukola Jaiyeola , Nagaraju Kerru, Oluwakemi Ebenezer and Ajay Bissessur*
DOI: 10.2174/0929867324666170712164400
Published on: 12 July, 2017